TGFB1 and Myocardial fibrosis: Another suggested mechanism by which chitosan reduces myocardial fibrosis is via the reduction of transforming growth factor beta (TGF-β), which causes inflammatory macrophages to no longer be effective with consequent myofibroblast transdifferentiation and matrix synthesis via the Smad protein-dependent pathway [31].